Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

6 structures for Q14332

Entry ID Method Resolution Chain Position Source
6C0B X-ray 250 A B 34-156 PDB
7N95 EM 410 A B 35-155 PDB
7N97 EM 510 A B 35-155 PDB
7N9S EM 510 A B 35-155 PDB
7X8P X-ray 224 A A/D 34-159 PDB
AF-Q14332-F1 Predicted AlphaFoldDB

353 variants for Q14332

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV000577910
rs1555657045
RCV002529036
CA399797946
377 W>* Autosomal dominant Robinow syndrome 2 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA8604757
RCV000678664
rs758351214
RCV002536313
413 R>Q Keratoconus [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA399798728
rs1223920489
VAR_083244
RCV001353073
RCV000577904
434 G>S Autosomal dominant Robinow syndrome 2 Autosomal dominant Robinow syndrome 1 probable disease-associated variant found in a patient with features of Robinow syndrome [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
CA399798732
rs1555657073
RCV000577887
VAR_081993
434 G>V Autosomal dominant Robinow syndrome 3 OMOD2; also found in a patient with features of Robinow syndrome [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV000577879
rs1555657074
CA658658623
434 G>V Autosomal dominant Robinow syndrome 2 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
VAR_081994 547 S>del OMOD2 [UniProt] Yes UniProt
VAR_081995 548 W>del OMOD2; decreased Wnt signaling [UniProt] Yes UniProt
TCGA novel 3 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1413946017
CA399789215
5 S>R No ClinGen
TOPMed
TCGA novel 7 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1391088820
CA399789254
8 P>T No ClinGen
gnomAD
rs1457585218
CA399789275
9 R>C No ClinGen
TOPMed
gnomAD
rs540777044
CA8604592
9 R>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA290947352
rs904819812
10 L>V No ClinGen
TOPMed
RCV000963514
rs753676516
11 L>MP No ClinVar
dbSNP
rs199790761
CA8604597
12 L>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8604598
rs150027138
RCV000963515
13 P>L No ClinGen
ClinVar
1000Genomes
TOPMed
dbSNP
gnomAD
CA399789475
rs1268657066
18 P>L No ClinGen
gnomAD
rs1568104858
CA399789473
18 P>S No ClinGen
Ensembl
rs1196775603
CA399789518
19 A>V No ClinGen
gnomAD
rs147715817
RCV000887091
CA8604607
CA8604606
21 G>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinVar
dbSNP
rs1409538143
CA399789548
21 G>V No ClinGen
gnomAD
rs767295801
CA8604608
22 P>L No ClinGen
ExAC
gnomAD
CA399789594
rs1598688431
23 A>S No ClinGen
Ensembl
CA8604610
rs749968550
25 F>L No ClinGen
ExAC
gnomAD
rs779506925
CA8604611
26 H>D No ClinGen
ExAC
gnomAD
CA8604612
rs748988013
26 H>R No ClinGen
ExAC
CA399789695
rs1235513068
27 G>E No ClinGen
gnomAD
rs754611548
CA8604613
CA8604614
27 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA399789751
rs1365650986
29 K>N No ClinGen
TOPMed
rs1007509516
CA290947460
31 I>L No ClinGen
TOPMed
rs1286034359
CA399789786
31 I>M No ClinGen
gnomAD
rs1315569415
CA399789793
32 S>T No ClinGen
gnomAD
CA290947468
rs1017947835
33 I>M No ClinGen
TOPMed
CA8604615
rs747271499
36 H>L No ClinGen
ExAC
TOPMed
gnomAD
CA399789882
rs747271499
36 H>P No ClinGen
ExAC
TOPMed
gnomAD
rs1159420624
CA399789904
37 G>C No ClinGen
TOPMed
CA8604618
rs142583858
41 P>R No ClinGen
ESP
ExAC
TOPMed
rs776956114
CA8604617
41 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs1483406071
CA399790052
43 S>A No ClinGen
gnomAD
TCGA novel 45 P>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399790290
rs1367854819
53 N>S No ClinGen
gnomAD
CA399790289
rs1367854819
53 N>T No ClinGen
gnomAD
CA290947517
rs909657426
54 Q>R No ClinGen
gnomAD
CA290947520
rs1026329445
55 T>A No ClinGen
TOPMed
gnomAD
CA8604624
rs761463887
60 L>F No ClinGen
ExAC
gnomAD
CA8604625
COSM384909
rs767518136
64 T>M lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA8604626
rs750365738
66 Q>* No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 73 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1244482185
CA399790972
82 V>L No ClinGen
gnomAD
rs1277393888
CA399791003
83 Q>P No ClinGen
gnomAD
CA290947549
rs984920143
84 C>Y No ClinGen
TOPMed
rs1274579640
COSM1750079
CA399791065
85 S>L urinary_tract [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA8604630
rs754629987
86 P>S No ClinGen
ExAC
gnomAD
CA399791343
rs1182259253
95 M>L No ClinGen
gnomAD
rs757523917
CA8604633
97 A>S No ClinGen
ExAC
gnomAD
rs1365920113
CA399791418
99 V>M No ClinGen
Ensembl
rs1375718768
CA399791505
104 E>K No ClinGen
TOPMed
rs746414947
CA8604635
108 P>Q No ClinGen
ExAC
gnomAD
CA8604637
rs201264228
113 I>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8604636
rs770414415
113 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA8604638
rs749318758
115 E>D No ClinGen
ExAC
gnomAD
rs1301874775
CA399791744
116 R>C No ClinGen
gnomAD
rs762062345
CA8604641
123 A>T No ClinGen
ExAC
gnomAD
rs972479309
CA290947640
125 M>T No ClinGen
gnomAD
CA399791906
rs1255640347
125 M>V No ClinGen
TOPMed
CA8604643
rs773045036
127 K>T No ClinGen
ExAC
TOPMed
gnomAD
CA8604644
rs760595884
128 F>L No ClinGen
ExAC
TOPMed
gnomAD
CA399792013
rs1255620991
130 F>V No ClinGen
gnomAD
TCGA novel 132 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399792091
rs1474583091
133 P>A No ClinGen
gnomAD
CA290947649
rs868688445
134 E>A No ClinGen
Ensembl
CA399792103
rs1248571035
134 E>K No ClinGen
gnomAD
CA399792123
rs1184280246
135 R>H No ClinGen
gnomAD
CA8604645
rs766237073
135 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA290947650
rs866001466
137 R>H No ClinGen
gnomAD
CA399792141
rs866001466
137 R>L No ClinGen
gnomAD
CA8604646
rs753404467
139 E>K No ClinGen
ExAC
gnomAD
CA399792201
rs1174987770
140 H>R No ClinGen
gnomAD
VAR_083242
rs759024435
CA8604647
142 P>L found in a patient with features of Robinow syndrome; unknown pathological significance [UniProt] No ClinGen
UniProt
ExAC
TOPMed
dbSNP
gnomAD
rs1339240115
CA399792264
143 R>P No ClinGen
TOPMed
TCGA novel 145 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1390054192
CA399792295
145 G>R No ClinGen
gnomAD
rs144916759
CA8604650
146 A>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1056170782
CA290947664
147 E>K No ClinGen
TOPMed
rs1470091490
CA399792341
148 Q>E No ClinGen
TOPMed
rs756747247
CA8604653
152 G>A No ClinGen
ExAC
gnomAD
rs1373700762
CA399792521
156 S>Y No ClinGen
TOPMed
rs749423345
CA399792524
157 E>K No ClinGen
ExAC
gnomAD
rs749423345
CA8604655
157 E>Q No ClinGen
ExAC
gnomAD
rs768891016
CA399792572
159 G>* No ClinGen
ExAC
TOPMed
gnomAD
rs779004987
CA8604657
159 G>A No ClinGen
ExAC
gnomAD
CA8604656
rs768891016
159 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA290947699
rs938790525
160 A>P No ClinGen
Ensembl
CA8604658
rs748334299
161 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs770903448
CA8604662
165 T>N No ClinGen
ExAC
gnomAD
CA399792696
rs1198566326
166 T>S No ClinGen
TOPMed
rs759427364
CA8604665
167 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1437285040
CA399792743
168 P>Q No ClinGen
gnomAD
rs1253611469
CA399792767
169 P>L No ClinGen
TOPMed
CA399792747
rs1292969671
169 P>T No ClinGen
gnomAD
rs1043572819
CA290947731
172 L>V No ClinGen
TOPMed
CA8604667
rs752191369
174 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs764673652
CA8604666
174 P>S No ClinGen
ExAC
gnomAD
rs762514513
CA8604668
175 G>D No ClinGen
ExAC
TOPMed
gnomAD
rs762514513
CA290947745
175 G>V No ClinGen
ExAC
TOPMed
gnomAD
CA8604669
CA399792885
rs530418343
177 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
NCI-TCGA
rs552299284
CA8604670
178 G>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1220216796
CA399792920
179 T>S No ClinGen
gnomAD
CA8604671
rs570404945
180 P>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs780528773
CA8604672
181 G>D No ClinGen
ExAC
gnomAD
CA290947793
rs1038929261
183 P>L No ClinGen
TOPMed
rs1598688743
CA399792991
184 G>D No ClinGen
Ensembl
rs1184407847
CA399793036
187 G>D No ClinGen
TOPMed
CA399793030
rs1469955991
187 G>S No ClinGen
gnomAD
CA399793046
rs1336876177
188 A>S No ClinGen
TOPMed
gnomAD
rs904495986
CA290947816
189 P>S No ClinGen
TOPMed
gnomAD
CA290947825
rs999364876
190 P>A No ClinGen
Ensembl
CA399793121
rs1416625449
194 T>A No ClinGen
gnomAD
CA8604674
rs532764830
197 H>Y No ClinGen
1000Genomes
ExAC
gnomAD
rs778865495
CA8604675
COSM1128688
199 F>L prostate [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1431700816
CA399793347
203 R>C No ClinGen
gnomAD
CA399793357
rs1208609685
203 R>H No ClinGen
TOPMed
rs1335328160
CA399793366
204 V>I No ClinGen
gnomAD
rs566397443
CA8604678
206 K>Q No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 206 K>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 209 S>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA290947889
rs745560735
211 L>R No ClinGen
Ensembl
rs1289503825
CA399793652
215 F>C No ClinGen
gnomAD
CA399793644
rs1598688787
215 F>L No ClinGen
Ensembl
CA8604682
rs745816253
217 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA290947895
rs1006227093
217 G>S No ClinGen
TOPMed
gnomAD
rs769703330
CA8604683
218 E>* No ClinGen
ExAC
gnomAD
RCV000736148
RCV002533764
CA8604684
rs375633511
219 R>C No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs375633511
CA399793713
219 R>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs762507541
CA8604685
219 R>H No ClinGen
ExAC
gnomAD
CA8604689
rs368248456
223 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA399793901
rs1598688833
227 P>L No ClinGen
Ensembl
CA8604691
rs754191382
228 A>P No ClinGen
ExAC
gnomAD
CA8604690
rs754191382
228 A>S No ClinGen
ExAC
gnomAD
COSM561006
CA399793929
rs1169257475
228 A>V lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
COSM3958431
CA8604693
rs371992723
229 R>L lung [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs1378636473
CA399793953
230 P>S No ClinGen
TOPMed
CA8604695
rs777673157
231 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1451633742
CA399794027
COSM3712336
235 F>L upper_aerodigestive_tract [Cosmic] No ClinGen
cosmic curated
gnomAD
CA399794065
rs1367185671
237 S>* No ClinGen
gnomAD
rs1234997586
CA399794083
238 Q>L No ClinGen
TOPMed
rs757410006
CA8604697
241 T>K No ClinGen
ExAC
gnomAD
CA8604699
rs745654767
242 R>P No ClinGen
ExAC
gnomAD
TCGA novel 243 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399794245
COSM979988
rs1443411666
244 A>V Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs775470381
CA8604701
246 L>F No ClinGen
ExAC
gnomAD
CA399794290
rs1466602342
247 W>C No ClinGen
gnomAD
RCV000885895
rs143455997
CA8604703
250 T>I No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA8604705
rs761564563
253 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA399794473
rs369254941
256 C>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1598688904
CA399794471
256 C>F No ClinGen
Ensembl
CA399794480
rs1334398387
257 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs759922644
CA8604708
259 T>A No ClinGen
ExAC
gnomAD
CA399794622
rs1222893148
262 T>A No ClinGen
TOPMed
TCGA novel 265 T>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399794717
rs1281130175
266 Y>F No ClinGen
TOPMed
CA8604709
rs769050190
COSM1383684
268 V>A large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA399794809
rs1330380393
269 D>H No ClinGen
TOPMed
CA8604710
rs753278694
270 M>R No ClinGen
ExAC
gnomAD
CA399794864
rs753278694
270 M>T No ClinGen
ExAC
gnomAD
rs1221438450
CA399794850
270 M>V No ClinGen
Ensembl
rs1234766566
CA399794923
272 R>L No ClinGen
gnomAD
CA8604711
rs758781030
273 F>L No ClinGen
ExAC
TOPMed
gnomAD
CA8604712
rs764170120
276 P>S No ClinGen
ExAC
gnomAD
TCGA novel 278 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 284 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs960229192
CA290948050
286 C>G No ClinGen
Ensembl
rs781375731
CA8604715
287 Y>H No ClinGen
ExAC
TOPMed
gnomAD
rs1445369464
CA399795210
288 T>A No ClinGen
gnomAD
CA290948061
rs541765661
COSM3819748
290 V>M Variant assessed as Somatic; impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
rs1247540055
CA399795384
296 A>V No ClinGen
gnomAD
TCGA novel 297 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8604717
rs540840394
299 V>M No ClinGen
1000Genomes
ExAC
gnomAD
CA399795485
rs1171120457
300 L>V No ClinGen
TOPMed
rs768414164
CA8604720
304 V>L No ClinGen
ExAC
gnomAD
rs1388042136
CA399795645
306 C>Y No ClinGen
gnomAD
CA399795687
rs1430553474
308 E>Q No ClinGen
TOPMed
CA8604723
rs771900202
309 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA8604722
rs747650126
309 R>S No ClinGen
ExAC
gnomAD
CA8604726
rs770215499
312 E>Q No ClinGen
ExAC
gnomAD
TCGA novel 314 G>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 314 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399795813
rs1348396900
314 G>V No ClinGen
gnomAD
CA399795878
rs1292652015
316 R>C No ClinGen
gnomAD
CA399795881
rs1490197432
316 R>L No ClinGen
gnomAD
CA290948117
rs1043290843
318 V>M No ClinGen
Ensembl
rs764576821
CA8604729
323 K>R No ClinGen
ExAC
gnomAD
CA290948120
rs925950278
324 K>E No ClinGen
gnomAD
rs925950278
COSM979993
CA399795998
324 K>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA399796075
rs1598689022
328 T>P No ClinGen
Ensembl
CA399796104
rs1362014589
330 L>I No ClinGen
gnomAD
CA290948131
rs1053647443
333 M>I No ClinGen
Ensembl
CA290948137
rs866732079
341 S>T No ClinGen
Ensembl
CA8604732
rs767549516
343 I>V No ClinGen
ExAC
gnomAD
TCGA novel 345 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 346 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1422204743
CA399797469
348 L>M No ClinGen
gnomAD
rs1283802196
CA399797601
353 F>L No ClinGen
TOPMed
rs1306672386
CA399797619
355 A>T No ClinGen
gnomAD
rs1334324882
CA399797643
356 A>G No ClinGen
gnomAD
rs1316342300
CA399797732
361 G>S No ClinGen
gnomAD
TCGA novel 362 H>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1269731273
CA399797752
362 H>R No ClinGen
TOPMed
rs1220274619
CA399797748
362 H>Y No ClinGen
TOPMed
gnomAD
TCGA novel 363 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs778973007
CA8604738
366 E>G No ClinGen
ExAC
TOPMed
gnomAD
CA290948221
rs866062060
368 N>K No ClinGen
Ensembl
CA8604739
rs747701116
368 N>T No ClinGen
ExAC
gnomAD
CA399797876
rs1598689082
371 Y>S No ClinGen
Ensembl
CA8604741
rs777369808
373 H>P No ClinGen
ExAC
gnomAD
rs1414226071
CA399797939
376 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
VAR_083243 377 W>del probable disease-associated variant found in a patient with features of Robinow syndrome [UniProt] No UniProt
rs746685961
CA8604743
379 V>L No ClinGen
ExAC
gnomAD
CA8604742
rs746685961
COSM1207712
379 V>M Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
TCGA novel 380 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 381 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8604745
rs530531830
381 A>T No ClinGen
1000Genomes
ExAC
gnomAD
rs1296057234
CA399797975
382 V>F No ClinGen
gnomAD
CA399798008
rs1420830591
385 I>T No ClinGen
TOPMed
CA8604746
rs769196121
386 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA8604747
rs774804882
386 T>I No ClinGen
ExAC
gnomAD
CA8604749
CA399798073
rs767602533
390 M>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
TOPMed
gnomAD
NCI-TCGA
rs1382604177
CA399798067
390 M>T No ClinGen
gnomAD
CA399798077
rs1299976629
391 G>R No ClinGen
gnomAD
CA399798076
rs1299976629
391 G>S No ClinGen
gnomAD
CA399798179
rs1316059026
398 L>M No ClinGen
TOPMed
TCGA novel 401 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1459890324
CA399798275
403 F>L No ClinGen
TOPMed
gnomAD
rs1419657640
CA399798311
406 L>F No ClinGen
gnomAD
CA399798352
rs1427401815
408 S>N No ClinGen
gnomAD
CA399798361
rs1167951005
409 L>M No ClinGen
gnomAD
rs765084011
CA8604755
410 D>N No ClinGen
ExAC
gnomAD
CA290948311
rs1005899385
411 P>R No ClinGen
Ensembl
CA8604756
rs371409349
412 L>M No ClinGen
ESP
ExAC
TOPMed
CA8604758
rs777341173
414 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA8604759
rs746494673
416 V>L No ClinGen
ExAC
gnomAD
TCGA novel 419 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399798533
rs1455744194
420 L>H No ClinGen
gnomAD
CA399798551
rs1383973704
421 F>L No ClinGen
TOPMed
rs1339183245
CA399798559
COSM1383688
422 V>M large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs1451148515
CA399798587
423 Y>* No ClinGen
gnomAD
rs756989889
CA399798616
426 I>F No ClinGen
ExAC
gnomAD
rs756989889
CA8604760
426 I>V No ClinGen
ExAC
gnomAD
RCV001310363
rs1555657073
434 G>A No ClinVar
dbSNP
CA8604763
rs769034717
436 V>M No ClinGen
ExAC
gnomAD
CA8604766
rs201422597
439 F>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs773401045
CA8604767
440 R>H No ClinGen
ExAC
gnomAD
rs867681109
COSM1383689
CA290948363
442 R>C large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
COSM979995
rs770035472
CA290948368
442 R>H large_intestine Variant assessed as Somatic; impact. endometrium [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
rs760651150
CA8604768
444 I>L No ClinGen
ExAC
gnomAD
CA8604769
rs766665442
444 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA8604770
rs776751080
445 M>K No ClinGen
ExAC
gnomAD
CA399798855
rs1161069652
445 M>V No ClinGen
TOPMed
rs772323293
CA8604771
448 D>G No ClinGen
ExAC
gnomAD
TCGA novel 448 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399798905
rs1480532152
448 D>Y No ClinGen
gnomAD
rs773532997
CA8604773
449 G>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 451 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8604774
rs758474512
451 K>T No ClinGen
ExAC
gnomAD
CA399799000
rs1346236408
456 E>Q No ClinGen
gnomAD
rs141791958
CA8604776
457 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs756686384
CA290948413
460 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs756686384
CA8604777
460 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA8604779
rs780709416
461 R>L No ClinGen
ExAC
gnomAD
CA8604778
rs780709416
461 R>P No ClinGen
ExAC
gnomAD
CA399799055
rs1343473493
462 I>L No ClinGen
gnomAD
CA8604781
rs779319509
463 G>S No ClinGen
ExAC
rs1316230624
CA399799084
464 V>D No ClinGen
gnomAD
COSM1207713
CA8604782
rs748501689
464 V>I large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA399799113
rs1598689293
466 S>C No ClinGen
Ensembl
rs1213062571
CA399799103
466 S>T No ClinGen
gnomAD
rs1490369116
CA399799121
467 V>E No ClinGen
gnomAD
rs970175049
CA399799117
467 V>L No ClinGen
TOPMed
rs970175049
CA290948446
467 V>M No ClinGen
TOPMed
CA399799129
rs1266251835
468 L>I No ClinGen
gnomAD
RCV000736149
CA399799137
rs1568105562
468 L>R No ClinGen
ClinVar
Ensembl
dbSNP
CA8604786
rs770938713
470 T>A No ClinGen
ExAC
gnomAD
rs966344285
CA290948462
472 P>L No ClinGen
TOPMed
gnomAD
rs1373093730
CA399799215
474 T>I No ClinGen
TOPMed
TCGA novel 474 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 475 I>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs759841056
CA8604788
475 I>V No ClinGen
ExAC
gnomAD
CA399799247
rs1598689326
476 V>I No ClinGen
Ensembl
CA8604789
rs765550610
477 I>T No ClinGen
ExAC
gnomAD
CA8604791
COSM4130144
rs762816431
482 Y>* thyroid [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA8604790
rs775481151
482 Y>H No ClinGen
ExAC
gnomAD
CA290948500
rs866012347
483 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1363873560
CA399799413
485 A>T No ClinGen
gnomAD
TCGA novel 487 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399799453
rs1568105587
488 E>K No ClinGen
Ensembl
rs1355758683
CA399799476
489 H>R No ClinGen
TOPMed
rs926219317
CA290948525
491 E>K No ClinGen
TOPMed
gnomAD
rs751478883
COSM979996
CA8604793
492 R>C liver endometrium Variant assessed as Somatic; 4.651e-05 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs1289359223
CA399799535
492 R>H No ClinGen
Ensembl
CA399799558
rs1423453742
493 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
TCGA novel 494 W>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399799587
rs1385421964
495 V>M No ClinGen
TOPMed
CA8604794
rs761755955
498 H>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 499 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1359549333
CA399799710
501 S>N No ClinGen
gnomAD
rs749932584
CA8604796
503 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 504 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs548910133
CA8604799
507 P>L No ClinGen
1000Genomes
ExAC
gnomAD
CA8604798
rs779659041
507 P>S No ClinGen
ExAC
gnomAD
RCV000957618
CA8604801
rs138090948
508 A>V No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1598689381
CA399799861
510 Y>C No ClinGen
Ensembl
rs1445321703
CA399799853
510 Y>H No ClinGen
gnomAD
CA399799884
rs1598689386
511 T>R No ClinGen
Ensembl
rs1238294571
CA399799918
512 P>Q No ClinGen
TOPMed
CA290948589
rs974602506
COSM1252899
513 R>H oesophagus [Cosmic] No ClinGen
cosmic curated
TOPMed
rs1183159973
CA399799934
514 M>V No ClinGen
gnomAD
CA8604804
rs781487182
517 D>N No ClinGen
ExAC
gnomAD
rs988811820
CA290948596
519 T>A No ClinGen
gnomAD
CA399800045
rs988811820
519 T>S No ClinGen
gnomAD
rs752446436
CA290948599
520 V>A No ClinGen
Ensembl
rs922721167
CA290948603
521 Y>C No ClinGen
TOPMed
gnomAD
rs1338626837
CA399800092
522 M>L No ClinGen
TOPMed
gnomAD
CA399800094
rs1338626837
522 M>V No ClinGen
TOPMed
gnomAD
TCGA novel 523 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399800123
rs1383384153
523 I>V No ClinGen
gnomAD
CA399800187
rs1568105634
527 M>V No ClinGen
Ensembl
CA290948610
rs1049775007
528 T>M No ClinGen
TOPMed
gnomAD
rs1047612015
CA290948618
533 I>V No ClinGen
TOPMed
rs1304561617
CA399800361
538 W>R No ClinGen
TOPMed
CA290948622
rs889616797
538 W>S No ClinGen
Ensembl
rs1344385392
CA399800398
540 W>* No ClinGen
TOPMed
rs1437629201
CA399800393
540 W>R No ClinGen
gnomAD
TCGA novel 540 W>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399800491
rs1598689448
546 H>P No ClinGen
Ensembl
CA399800498
rs1462119468
546 H>Q No ClinGen
TOPMed
gnomAD
rs1420668927
CA399800488
546 H>Y No ClinGen
TOPMed
rs1568105666
CA399800526
548 W>* No ClinGen
Ensembl
TCGA novel 548 W>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA290948628
rs942022627
549 R>K No ClinGen
TOPMed
CA8604811
rs761727833
550 K>R No ClinGen
ExAC
gnomAD
rs201750182
CA8604812
553 T>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8604813
rs749987687
554 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs1178260886
CA399800619
555 L>F No ClinGen
gnomAD
rs1598689467
CA399800645
557 N>T No ClinGen
Ensembl
rs144687330
CA8604815
559 R>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs753511101
CA399800672
559 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs753511101
CA8604816
COSM317385
559 R>Q lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs1038724972
CA399800687
560 H>Q No ClinGen
TOPMed
gnomAD
CA290948672
rs148517314
561 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
NCI-TCGA
gnomAD
rs1213204785
CA399800732
563 T>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1370092002
CA399800756
565 V>G No ClinGen
gnomAD
CA399800754
rs1265443674
565 V>L No ClinGen
gnomAD

2 associated diseases with Q14332

[MIM: 164745]: Omodysplasia 2 (OMOD2)

A rare autosomal dominant skeletal dysplasia characterized by short humeri, radial head dislocation, short first metacarpals, facial dysmorphism and genitourinary anomalies. {ECO:0000269|PubMed:25759469, ECO:0000269|PubMed:29230162, ECO:0000269|PubMed:29383834, ECO:0000269|PubMed:30455931}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A rare autosomal dominant skeletal dysplasia characterized by short humeri, radial head dislocation, short first metacarpals, facial dysmorphism and genitourinary anomalies. {ECO:0000269|PubMed:25759469, ECO:0000269|PubMed:29230162, ECO:0000269|PubMed:29383834, ECO:0000269|PubMed:30455931}. Note=The disease is caused by variants affecting the gene represented in this entry.

4 regional properties for Q14332

Type Name Position InterPro Accession
domain Frizzled/Smoothened, transmembrane domain 234 - 558 IPR000539
domain GPCR, family 2-like, transmembrane domain 244 - 547 IPR017981
domain Frizzled domain 34 - 155 IPR020067
domain Frizzled 2, cysteine-rich domain 35 - 161 IPR041778

Functions

Description
EC Number
Subcellular Localization
  • Membrane; Multi-pass membrane protein
  • Cell membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
clathrin-coated endocytic vesicle membrane The lipid bilayer surrounding a clathrin-coated endocytic vesicle.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
focal adhesion A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ).
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

4 GO annotations of molecular function

Name Definition
G protein-coupled receptor activity Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
PDZ domain binding Binding to a PDZ domain of a protein, a domain found in diverse signaling proteins.
Wnt receptor activity Combining with a Wnt protein and transmitting the signal across the plasma membrane to initiate a change in cell activity.
Wnt-protein binding Binding to a Wnt-protein, a secreted growth factor involved in signaling.

15 GO annotations of biological process

Name Definition
canonical Wnt signaling pathway The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
cochlea morphogenesis The process in which the cochlea is generated and organized.
endothelial cell differentiation The process in which a mesodermal, bone marrow or neural crest cell acquires specialized features of an endothelial cell, a thin flattened cell. A layer of such cells lines the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium.
hard palate development The biological process whose specific outcome is the progression of the hard palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. The hard palate is the anterior portion of the palate consisting of bone and mucous membranes.
inner ear receptor cell development The process whose specific outcome is the progression of an inner ear receptor cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
membranous septum morphogenesis The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum.
muscular septum morphogenesis The process in which the muscular septum is generated and organized. The muscular septum is the lower part of the ventricular septum.
neuron differentiation The process in which a relatively unspecialized cell acquires specialized features of a neuron.
outflow tract morphogenesis The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
planar cell polarity pathway involved in neural tube closure The series of molecular signals initiated by binding of a Wnt protein to a receptor on the surface of the target cell where activated receptors signal via downstream effectors that modulates the establishment of planar polarity contributing to neural tube closure.
positive regulation of DNA-binding transcription factor activity Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
positive regulation of DNA-templated transcription Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
sensory perception of smell The series of events required for an organism to receive an olfactory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Olfaction involves the detection of chemical composition of an organism's ambient medium by chemoreceptors. This is a neurological process.
Wnt signaling pathway The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.
Wnt signaling pathway, planar cell polarity pathway The series of molecular signals initiated by binding of a Wnt protein to a receptor on the surface of the target cell where activated receptors signal via downstream effectors including C-Jun N-terminal kinase (JNK) to modulate cytoskeletal elements and control cell polarity.

23 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O19116 SFRP1 Secreted frizzled-related protein 1 Bos taurus (Bovine) PR
Q9DEQ4 SFRP1 Secreted frizzled-related protein 1 Gallus gallus (Chicken) PR
O57328 FZD1 Frizzled-1 Gallus gallus (Chicken) PR
Q9IA96 SFRP2 Secreted frizzled-related protein 2 Gallus gallus (Chicken) PR
O00144 FZD9 Frizzled-9 Homo sapiens (Human) PR
O75084 FZD7 Frizzled-7 Homo sapiens (Human) PR
Q6FHJ7 SFRP4 Secreted frizzled-related protein 4 Homo sapiens (Human) PR
Q8N474 SFRP1 Secreted frizzled-related protein 1 Homo sapiens (Human) PR
Q96HF1 SFRP2 Secreted frizzled-related protein 2 Homo sapiens (Human) PR
Q9ULW2 FZD10 Frizzled-10 Homo sapiens (Human) PR
Q9UP38 FZD1 Frizzled-1 Homo sapiens (Human) PR
O60353 FZD6 Frizzled-6 Homo sapiens (Human) PR
Q9Z1N6 Sfrp4 Secreted frizzled-related sequence protein 4 Mus musculus (Mouse) PR
P97299 Sfrp2 Secreted frizzled-related protein 2 Mus musculus (Mouse) PR
Q8C4U3 Sfrp1 Secreted frizzled-related protein 1 Mus musculus (Mouse) PR
O70421 Fzd1 Frizzled-1 Mus musculus (Mouse) PR
Q61090 Fzd7 Frizzled-7 Mus musculus (Mouse) PR
Q9JIP6 Fzd2 Frizzled-2 Mus musculus (Mouse) PR
Q08463 Fzd1 Frizzled-1 Rattus norvegicus (Rat) PR
Q9JLS4 Sfrp4 Secreted frizzled-related protein 4 Rattus norvegicus (Rat) PR
Q08464 Fzd2 Frizzled-2 Rattus norvegicus (Rat) PR
Q7YRN1 SFRP4 Secreted frizzled-related protein 4 Macaca mulatta (Rhesus macaque) PR
Q5BL72 fzd7 Frizzled-7 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MRPRSALPRL LLPLLLLPAA GPAQFHGEKG ISIPDHGFCQ PISIPLCTDI AYNQTIMPNL
70 80 90 100 110 120
LGHTNQEDAG LEVHQFYPLV KVQCSPELRF FLCSMYAPVC TVLEQAIPPC RSICERARQG
130 140 150 160 170 180
CEALMNKFGF QWPERLRCEH FPRHGAEQIC VGQNHSEDGA PALLTTAPPP GLQPGAGGTP
190 200 210 220 230 240
GGPGGGGAPP RYATLEHPFH CPRVLKVPSY LSYKFLGERD CAAPCEPARP DGSMFFSQEE
250 260 270 280 290 300
TRFARLWILT WSVLCCASTF FTVTTYLVDM QRFRYPERPI IFLSGCYTMV SVAYIAGFVL
310 320 330 340 350 360
QERVVCNERF SEDGYRTVVQ GTKKEGCTIL FMMLYFFSMA SSIWWVILSL TWFLAAGMKW
370 380 390 400 410 420
GHEAIEANSQ YFHLAAWAVP AVKTITILAM GQIDGDLLSG VCFVGLNSLD PLRGFVLAPL
430 440 450 460 470 480
FVYLFIGTSF LLAGFVSLFR IRTIMKHDGT KTEKLERLMV RIGVFSVLYT VPATIVIACY
490 500 510 520 530 540
FYEQAFREHW ERSWVSQHCK SLAIPCPAHY TPRMSPDFTV YMIKYLMTLI VGITSGFWIW
550 560
SGKTLHSWRK FYTRLTNSRH GETTV